Newron Pharmaceuticals S.p.A. (FRA:NP5)
Germany flag Germany · Delayed Price · Currency is EUR
21.55
-1.15 (-5.07%)
Feb 20, 2026, 4:00 PM EST

Revenue by Segment

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Research and Development of Pharmaceutical Drugs
51.39M9.06M6.09M5.76M5.26M
Research and Development of Pharmaceutical Drugs Growth
467.41%48.62%5.76%9.59%-25.29%
Total
51.39M9.06M6.09M5.76M5.26M
Total Growth
467.41%48.62%5.76%9.59%-25.29%
Source: S&P Global Market Intelligence.